Amicus Therapeutics, Inc. (FOLD) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Total operating expenses: 46.72M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total operating expenses: 46.72M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q3 EPS of ($0.28), $0.05 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.07 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearway Energy names new CFO and controller amid leadership shuffle
- Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
